Interactions of fatty acids with the calcium release channel in malignant hyperthermia.
Fletcher
J E
JE
Department of Anesthesiology, Hahnemann University, Philadelphia, Pennsylvania 19102-1192.
Rosenberg
H
H
Beech
J
J
D000818:Animals; D002110:Caffeine / Q000494:pharmacology; D015220:Calcium Channels / Q000187:drug effects / Q000378:metabolism*; D005227:Fatty Acids / Q000378:metabolism / Q000494:pharmacology*; D006221:Halothane / Q000494:pharmacology; D006736:Horses; D006801:Humans; D007545:Isoproterenol / Q000494:pharmacology; D008049:Lipase / Q000378:metabolism; D008305:Malignant Hyperthermia / Q000175:diagnosis / Q000378:metabolism*; D009124:Muscle Proteins / Q000378:metabolism; D010672:Phenytoin / Q000494:pharmacology; D012433:Ryanodine / Q000494:pharmacology; D013390:Succinylcholine / Q000494:pharmacology; D013552:Swine; D014280:Triglycerides / Q000494:pharmacology
D015220:Calcium Channels; D005227:Fatty Acids; D009124:Muscle Proteins; D014280:Triglycerides; D012433:Ryanodine; D002110:Caffeine; D010672:Phenytoin; D008049:Lipase; D013390:Succinylcholine; D007545:Isoproterenol; D006221:Halothane